AGLAEAPHARMA

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Aug 2023 filing date already counts against anyone who files later.

Record

Serial number

98146484

Mark type

Stylized text

Filed

23 Aug 2023

Published for opposition

16 Sept 2025

Attorney of record

Deborah E. Greaves

Goods and services

• Class 005 — Pharmaceuticals: Antiallergic medicines; Effervescent analgesic pharmaceutical preparations; Medicinal syrups for the treatment of pain, glaucoma and tumors; Medicines for dental purposes; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of pain, glaucoma and tumors; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the relief of insect bites; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Veterinary preparations, namely, pain relief medication; Pharmaceutical preparations for treating hypertension
• Class 042 — Scientific and technological services: Medical research; Pharmaceutical research and development

Owner

• AGLAEAPHARMA, INC., Camden City, DE, US
• AGLAEAPHARMA, INC., Camden City, DE, US

Prosecution history

• 11 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 16 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 16 Sept 2025 — PUBLISHED FOR OPPOSITION
• 10 Sept 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 10 Sept 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 10 Sept 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 10 Sept 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 10 Sept 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 10 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 19 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 16 Aug 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
• 28 Mar 2025 — ASSIGNED TO EXAMINER
• 27 Jan 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
• 24 Apr 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 24 Apr 2024 — LETTER OF SUSPENSION E-MAILED